Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,845.97 -31.08 (-0.39%) Bitcoin USD
64,741.45 +2,510.19 (+4.03%) CMC Crypto 200
1,336.55 +23.92 (+1.86%)
Novo Nordisk A/S (NVO)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 550.36B |
| Enterprise value | 549.90B |
| Trailing P/E | 46.31 |
| Forward P/E | 37.59 |
| PEG ratio (5-yr expected) | 2.39 |
| Price/sales (ttm) | 16.69 |
| Price/book (mrq) | 36.11 |
| Enterprise value/revenue | 2.37 |
| Enterprise value/EBITDA | 4.80 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.19 |
| 52-week change 3 | 42.20% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 138.28 |
| 52-week low 3 | 75.56 |
| 50-day moving average 3 | 126.07 |
| 200-day moving average 3 | 103.57 |
Share statistics
| Avg vol (3-month) 3 | 5.06M |
| Avg vol (10-day) 3 | 3.18M |
| Shares outstanding 5 | 4.46B |
| Implied shares outstanding 6 | 4.48B |
| Float 8 | 3.19B |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 9.30% |
| Shares short (28 Mar 2024) 4 | 2.83M |
| Short ratio (28 Mar 2024) 4 | 0.5 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.06% |
| Shares short (prior month 29 Feb 2024) 4 | 4.88M |
Dividends & splits
| Forward annual dividend rate 4 | 1.37 |
| Forward annual dividend yield 4 | 1.12% |
| Trailing annual dividend rate 3 | 9.40 |
| Trailing annual dividend yield 3 | 7.55% |
| 5-year average dividend yield 4 | 1.63 |
| Payout ratio 4 | 37.84% |
| Dividend date 3 | 02 Apr 2024 |
| Ex-dividend date 4 | 22 Mar 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 20 Sept 2023 |
Financial highlights
Currency in DKK.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 36.03% |
| Operating margin (ttm) | 42.79% |
Management effectiveness
| Return on assets (ttm) | 23.39% |
| Return on equity (ttm) | 88.07% |
Income statement
| Revenue (ttm) | 232.26B |
| Revenue per share (ttm) | 51.81 |
| Quarterly revenue growth (yoy) | 37.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 109.81B |
| Net income avi to common (ttm) | 83.68B |
| Diluted EPS (ttm) | 2.65 |
| Quarterly earnings growth (yoy) | 61.60% |
Balance sheet
| Total cash (mrq) | 30.23B |
| Total cash per share (mrq) | 6.78 |
| Total debt (mrq) | 27.01B |
| Total debt/equity (mrq) | 25.34% |
| Current ratio (mrq) | 0.82 |
| Book value per share (mrq) | 23.90 |
Cash flow statement
| Operating cash flow (ttm) | 108.91B |
| Levered free cash flow (ttm) | 54.1B |
© 2024 Yahoo. All rights reserved.